Starpharma Holdings - Stock Price History | SPHRY

Historical daily share price chart and data for Starpharma Holdings since 1969 adjusted for splits. The latest closing stock price for Starpharma Holdings as of December 31, 1969 is 0.00.
  • The all-time high Starpharma Holdings stock closing price was 0.00 on December 31, 1969.
  • The Starpharma Holdings 52-week high stock price is 0.00, which is NAN% above the current share price.
  • The Starpharma Holdings 52-week low stock price is 0.00, which is NAN% below the current share price.
  • The average Starpharma Holdings stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Starpharma Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.153B $0.002B
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.600B 9.14
GSK (GSK) United Kingdom $61.519B 7.39
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.876B 0.00
QIAGEN (QGEN) Netherlands $9.539B 15.97
Ginkgo Bioworks Holdings (DNA) United States $5.604B 0.00
Myovant Sciences (MYOV) United Kingdom $2.344B 0.00
Arcus Biosciences (RCUS) United States $1.891B 36.90
Emergent Biosolutions (EBS) United States $1.051B 6.09
ADC Therapeutics SA (ADCT) Switzerland $0.371B 0.00
Zymeworks (ZYME) Canada $0.344B 0.00
Enzo Biochem (ENZ) United States $0.115B 0.00
Gelesis Holdings (GLS) United States $0.082B 0.00
SQZ Biotechnologies (SQZ) United States $0.067B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00